Anavex Life Sciences (AVXL) Cash & Equivalents (2009 - 2026)
Anavex Life Sciences (AVXL) posted Cash & Equivalents of $118.33 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 17.0% from $101.16 million a year earlier but down 7.1% from the prior quarter.
Powered by 
Analysis
Anavex Life Sciences (AVXL) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Anavex Life Sciences' Cash & Equivalents came in at $102.58 million, down 22.4% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 28.5% (FY2020 to FY2025).
- In prior fiscal years, Anavex Life Sciences' Cash & Equivalents was $132.19 million in FY2024 (-12.5%), $151.02 million in FY2023 (+1.3%), $149.16 million in FY2022 (-1.9%) and $152.11 million in FY2021 (+420.0%).
- Quarterly Cash & Equivalents has run from a low of $101.16 million in fiscal Q3 2025 to a high of $154.82 million in fiscal Q3 2023 over five years.
- On a year-over-year basis, Cash & Equivalents has increased in each of the last three quarters, with an average decline of 7.3% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was fiscal Q4 2021, with growth of 420.0%; the weakest was fiscal Q3 2025, with a decline of 27.1%.
- According to Business Quant data, Cash & Equivalents for the three prior fiscal quarters was $127.42 million (Q2 2026), $131.75 million (Q1 2026) and $102.58 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Anavex Life Sciences | 104.75 Mn | -375.33 Mn | - | 118.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 118.33 Mn |
| Mar 31, 2026 | 127.42 Mn |
| Dec 31, 2025 | 131.75 Mn |
| Sep 30, 2025 | 102.58 Mn |
| Jun 30, 2025 | 101.16 Mn |
| Mar 31, 2025 | 115.77 Mn |
| Dec 31, 2024 | 120.78 Mn |
| Sep 30, 2024 | 132.19 Mn |
| Jun 30, 2024 | 138.76 Mn |
| Mar 31, 2024 | 139.39 Mn |
| Dec 31, 2023 | 143.77 Mn |
| Sep 30, 2023 | 151.02 Mn |
| Jun 30, 2023 | 154.82 Mn |
| Mar 31, 2023 | 153.47 Mn |
| Dec 31, 2022 | 143.62 Mn |
| Sep 30, 2022 | 149.16 Mn |
| Jun 30, 2022 | 153.20 Mn |
| Mar 31, 2022 | 153.34 Mn |
| Dec 31, 2021 | 151.15 Mn |
| Sep 30, 2021 | 152.11 Mn |
API Access
Anavex Life Sciences Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();